Achieve Life Sciences, Inc. (ACHV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 216.67M |
| Enterprise Value | 210.69M |
| P/E Ratio | -4.55 |
| PEG Ratio | -0.29 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 25.5 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.04 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.57 |
| Return On Equity | -1.93 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -228,000 |
| EBITDA | -53.6M |
| Net Income | -54.65M |
| Diluted EPS | -1.25 |
| Total Cash | 29.27M |
| Total Cash/Share | 0.55 |
| Total Debt | 14.95M |
| Total Debt/Equity | 1.4 |
| Current Ratio | 2.62 |
| Book Value Per Share | 0.2 |
| 52-Week Change | 32.81 |
| 52-Week High | 6.16 |
| 52-Week Low | 2 |
| Moving Average 50 Days | 4.83 |
| Moving Average 200 Days | 4.34 |
| Average Volume | 1.65M |
| Shares Outstanding | 102.66M |
| % Held by Institutions | 49.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | July 31, 2020 |